Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP

K-Number: K930189 · 1993-08-06

ApplicantDow Corning Wright
Decision Date1993-08-06
Product CodeJWH
Advisory CommitteeOR
DecisionSubstantially Equivalent for Some Indications

Device Summary

ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP is the device name listed in this FDA 510(k) record. The listed applicant is Dow Corning Wright. It received FDA 510(k) clearance on 1993-08-06 under 510(k) number K930189. The device is classified under product code JWH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent for Some Indications.

Frequently Asked Questions

What is the ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP?

ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP is a medical device that received FDA 510(k) clearance on 1993-08-06. The listed applicant is Dow Corning Wright. The 510(k) number is K930189.

When did ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP receive FDA 510(k) clearance?

ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP received FDA 510(k) clearance on 1993-08-06, under 510(k) number K930189.

Who is the listed applicant for ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP?

The FDA 510(k) record lists Dow Corning Wright as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP?

The FDA product code for ORTHOLOC(R) ADVANTIM(TM) POSTERIOR STAB FEMOR COMP is JWH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Dow Corning Wright as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K932210ORTHOLOC ADVANTIM REVISION FEMORAL COMPONENTK932911ORTHOLOC ADVANTIM L.S. TIBIAL COMPONENTK934354LACEY ALL POLYETHYLENE TIBIAL COMPONENTK932222SLT FEMORAL HEADK932858ORTHOLOC ADVANTIM TIBIAL BASE COMPONENTK930228ORTHOLOC ADVANTIM TIBIAL STEM 5 DEGREE

View all 74 devices →

Related Devices (Code: JWH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262057GMK ExtensionMedacta International SAK260063GSPE SpacerThe General Hospital Corporation, d/b/a MassachusettsK262293EVOLUTION MPX™ Total Knee SystemSuzhou Microport Orthorecon Co., Ltd.K262341b-ONE® Mobio™ Total Knee System Revision Cemented Tibial Augments, Stem Extensions and Press-Fit Stem ExtensionsB-One Ortho, Corp.K262130ATTUNE Revision Knee SystemDepuy Orthopaedics, Inc.K253961SK Knee SystemJust Medical Devices (Tianjin) Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑